0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Plant Derivative Drug Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-36W5705
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Plant Derivative Drug Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Plant Derivative Drug Market Research Report 2025

Code: QYRE-Auto-36W5705
Report
July 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Plant Derivative Drug Market Size

The global market for Plant Derivative Drug was valued at US$ 39810 million in the year 2024 and is projected to reach a revised size of US$ 55020 million by 2031, growing at a CAGR of 4.8% during the forecast period.

Plant Derivative Drug Market

Plant Derivative Drug Market

A botanical drug product is intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in humans.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Plant Derivative Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plant Derivative Drug.
The Plant Derivative Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Plant Derivative Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plant Derivative Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Plant Derivative Drug Market Report

Report Metric Details
Report Name Plant Derivative Drug Market
Accounted market size in year US$ 39810 million
Forecasted market size in 2031 US$ 55020 million
CAGR 4.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Cardiovascular
  • Tumor
  • Respiratory System
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao, Tasly Holding Group, Bionorica Se, Huarun 999, Taiji, Weleda, Kwangdong, GW Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Plant Derivative Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Plant Derivative Drug Market growing?

Ans: The Plant Derivative Drug Market witnessing a CAGR of 4.8% during the forecast period 2025-2031.

What is the Plant Derivative Drug Market size in 2031?

Ans: The Plant Derivative Drug Market size in 2031 will be US$ 55020 million.

Who are the main players in the Plant Derivative Drug Market report?

Ans: The main players in the Plant Derivative Drug Market are Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao, Tasly Holding Group, Bionorica Se, Huarun 999, Taiji, Weleda, Kwangdong, GW Pharmaceuticals

What are the Application segmentation covered in the Plant Derivative Drug Market report?

Ans: The Applications covered in the Plant Derivative Drug Market report are Cardiovascular, Tumor, Respiratory System, Other

What are the Type segmentation covered in the Plant Derivative Drug Market report?

Ans: The Types covered in the Plant Derivative Drug Market report are Prescription Drug, OTC

Recommended Reports

Herbal & Botanical Drugs

Disease Treatment Drugs

Herbal Supplement Products

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plant Derivative Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Prescription Drug
1.2.3 OTC
1.3 Market by Application
1.3.1 Global Plant Derivative Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cardiovascular
1.3.3 Tumor
1.3.4 Respiratory System
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Plant Derivative Drug Market Perspective (2020-2031)
2.2 Global Plant Derivative Drug Growth Trends by Region
2.2.1 Global Plant Derivative Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Plant Derivative Drug Historic Market Size by Region (2020-2025)
2.2.3 Plant Derivative Drug Forecasted Market Size by Region (2026-2031)
2.3 Plant Derivative Drug Market Dynamics
2.3.1 Plant Derivative Drug Industry Trends
2.3.2 Plant Derivative Drug Market Drivers
2.3.3 Plant Derivative Drug Market Challenges
2.3.4 Plant Derivative Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plant Derivative Drug Players by Revenue
3.1.1 Global Top Plant Derivative Drug Players by Revenue (2020-2025)
3.1.2 Global Plant Derivative Drug Revenue Market Share by Players (2020-2025)
3.2 Global Plant Derivative Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Plant Derivative Drug Revenue
3.4 Global Plant Derivative Drug Market Concentration Ratio
3.4.1 Global Plant Derivative Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plant Derivative Drug Revenue in 2024
3.5 Global Key Players of Plant Derivative Drug Head office and Area Served
3.6 Global Key Players of Plant Derivative Drug, Product and Application
3.7 Global Key Players of Plant Derivative Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Plant Derivative Drug Breakdown Data by Type
4.1 Global Plant Derivative Drug Historic Market Size by Type (2020-2025)
4.2 Global Plant Derivative Drug Forecasted Market Size by Type (2026-2031)
5 Plant Derivative Drug Breakdown Data by Application
5.1 Global Plant Derivative Drug Historic Market Size by Application (2020-2025)
5.2 Global Plant Derivative Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Plant Derivative Drug Market Size (2020-2031)
6.2 North America Plant Derivative Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Plant Derivative Drug Market Size by Country (2020-2025)
6.4 North America Plant Derivative Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Plant Derivative Drug Market Size (2020-2031)
7.2 Europe Plant Derivative Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Plant Derivative Drug Market Size by Country (2020-2025)
7.4 Europe Plant Derivative Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plant Derivative Drug Market Size (2020-2031)
8.2 Asia-Pacific Plant Derivative Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Plant Derivative Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Plant Derivative Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Plant Derivative Drug Market Size (2020-2031)
9.2 Latin America Plant Derivative Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Plant Derivative Drug Market Size by Country (2020-2025)
9.4 Latin America Plant Derivative Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plant Derivative Drug Market Size (2020-2031)
10.2 Middle East & Africa Plant Derivative Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Plant Derivative Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Plant Derivative Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Buchang Pharmaceuticals
11.1.1 Buchang Pharmaceuticals Company Details
11.1.2 Buchang Pharmaceuticals Business Overview
11.1.3 Buchang Pharmaceuticals Plant Derivative Drug Introduction
11.1.4 Buchang Pharmaceuticals Revenue in Plant Derivative Drug Business (2020-2025)
11.1.5 Buchang Pharmaceuticals Recent Development
11.2 China TCM
11.2.1 China TCM Company Details
11.2.2 China TCM Business Overview
11.2.3 China TCM Plant Derivative Drug Introduction
11.2.4 China TCM Revenue in Plant Derivative Drug Business (2020-2025)
11.2.5 China TCM Recent Development
11.3 Tsumura
11.3.1 Tsumura Company Details
11.3.2 Tsumura Business Overview
11.3.3 Tsumura Plant Derivative Drug Introduction
11.3.4 Tsumura Revenue in Plant Derivative Drug Business (2020-2025)
11.3.5 Tsumura Recent Development
11.4 Schwabe
11.4.1 Schwabe Company Details
11.4.2 Schwabe Business Overview
11.4.3 Schwabe Plant Derivative Drug Introduction
11.4.4 Schwabe Revenue in Plant Derivative Drug Business (2020-2025)
11.4.5 Schwabe Recent Development
11.5 Tong Ren Tang
11.5.1 Tong Ren Tang Company Details
11.5.2 Tong Ren Tang Business Overview
11.5.3 Tong Ren Tang Plant Derivative Drug Introduction
11.5.4 Tong Ren Tang Revenue in Plant Derivative Drug Business (2020-2025)
11.5.5 Tong Ren Tang Recent Development
11.6 Jumpcan Pharmaceutical
11.6.1 Jumpcan Pharmaceutical Company Details
11.6.2 Jumpcan Pharmaceutical Business Overview
11.6.3 Jumpcan Pharmaceutical Plant Derivative Drug Introduction
11.6.4 Jumpcan Pharmaceutical Revenue in Plant Derivative Drug Business (2020-2025)
11.6.5 Jumpcan Pharmaceutical Recent Development
11.7 Guangzhou Baiyunshan Pharmaceutical
11.7.1 Guangzhou Baiyunshan Pharmaceutical Company Details
11.7.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
11.7.3 Guangzhou Baiyunshan Pharmaceutical Plant Derivative Drug Introduction
11.7.4 Guangzhou Baiyunshan Pharmaceutical Revenue in Plant Derivative Drug Business (2020-2025)
11.7.5 Guangzhou Baiyunshan Pharmaceutical Recent Development
11.8 Yunnan Baiyao
11.8.1 Yunnan Baiyao Company Details
11.8.2 Yunnan Baiyao Business Overview
11.8.3 Yunnan Baiyao Plant Derivative Drug Introduction
11.8.4 Yunnan Baiyao Revenue in Plant Derivative Drug Business (2020-2025)
11.8.5 Yunnan Baiyao Recent Development
11.9 Tasly Holding Group
11.9.1 Tasly Holding Group Company Details
11.9.2 Tasly Holding Group Business Overview
11.9.3 Tasly Holding Group Plant Derivative Drug Introduction
11.9.4 Tasly Holding Group Revenue in Plant Derivative Drug Business (2020-2025)
11.9.5 Tasly Holding Group Recent Development
11.10 Bionorica Se
11.10.1 Bionorica Se Company Details
11.10.2 Bionorica Se Business Overview
11.10.3 Bionorica Se Plant Derivative Drug Introduction
11.10.4 Bionorica Se Revenue in Plant Derivative Drug Business (2020-2025)
11.10.5 Bionorica Se Recent Development
11.11 Huarun 999
11.11.1 Huarun 999 Company Details
11.11.2 Huarun 999 Business Overview
11.11.3 Huarun 999 Plant Derivative Drug Introduction
11.11.4 Huarun 999 Revenue in Plant Derivative Drug Business (2020-2025)
11.11.5 Huarun 999 Recent Development
11.12 Taiji
11.12.1 Taiji Company Details
11.12.2 Taiji Business Overview
11.12.3 Taiji Plant Derivative Drug Introduction
11.12.4 Taiji Revenue in Plant Derivative Drug Business (2020-2025)
11.12.5 Taiji Recent Development
11.13 Weleda
11.13.1 Weleda Company Details
11.13.2 Weleda Business Overview
11.13.3 Weleda Plant Derivative Drug Introduction
11.13.4 Weleda Revenue in Plant Derivative Drug Business (2020-2025)
11.13.5 Weleda Recent Development
11.14 Kwangdong
11.14.1 Kwangdong Company Details
11.14.2 Kwangdong Business Overview
11.14.3 Kwangdong Plant Derivative Drug Introduction
11.14.4 Kwangdong Revenue in Plant Derivative Drug Business (2020-2025)
11.14.5 Kwangdong Recent Development
11.15 GW Pharmaceuticals
11.15.1 GW Pharmaceuticals Company Details
11.15.2 GW Pharmaceuticals Business Overview
11.15.3 GW Pharmaceuticals Plant Derivative Drug Introduction
11.15.4 GW Pharmaceuticals Revenue in Plant Derivative Drug Business (2020-2025)
11.15.5 GW Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Plant Derivative Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Prescription Drug
 Table 3. Key Players of OTC
 Table 4. Global Plant Derivative Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Plant Derivative Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Plant Derivative Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Plant Derivative Drug Market Share by Region (2020-2025)
 Table 8. Global Plant Derivative Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Plant Derivative Drug Market Share by Region (2026-2031)
 Table 10. Plant Derivative Drug Market Trends
 Table 11. Plant Derivative Drug Market Drivers
 Table 12. Plant Derivative Drug Market Challenges
 Table 13. Plant Derivative Drug Market Restraints
 Table 14. Global Plant Derivative Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Plant Derivative Drug Market Share by Players (2020-2025)
 Table 16. Global Top Plant Derivative Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plant Derivative Drug as of 2024)
 Table 17. Ranking of Global Top Plant Derivative Drug Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Plant Derivative Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Plant Derivative Drug, Headquarters and Area Served
 Table 20. Global Key Players of Plant Derivative Drug, Product and Application
 Table 21. Global Key Players of Plant Derivative Drug, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Plant Derivative Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Plant Derivative Drug Revenue Market Share by Type (2020-2025)
 Table 25. Global Plant Derivative Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Plant Derivative Drug Revenue Market Share by Type (2026-2031)
 Table 27. Global Plant Derivative Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Plant Derivative Drug Revenue Market Share by Application (2020-2025)
 Table 29. Global Plant Derivative Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Plant Derivative Drug Revenue Market Share by Application (2026-2031)
 Table 31. North America Plant Derivative Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Plant Derivative Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Plant Derivative Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Plant Derivative Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Plant Derivative Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Plant Derivative Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Plant Derivative Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Plant Derivative Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Plant Derivative Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Plant Derivative Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Plant Derivative Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Plant Derivative Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Plant Derivative Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Plant Derivative Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Plant Derivative Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Buchang Pharmaceuticals Company Details
 Table 47. Buchang Pharmaceuticals Business Overview
 Table 48. Buchang Pharmaceuticals Plant Derivative Drug Product
 Table 49. Buchang Pharmaceuticals Revenue in Plant Derivative Drug Business (2020-2025) & (US$ Million)
 Table 50. Buchang Pharmaceuticals Recent Development
 Table 51. China TCM Company Details
 Table 52. China TCM Business Overview
 Table 53. China TCM Plant Derivative Drug Product
 Table 54. China TCM Revenue in Plant Derivative Drug Business (2020-2025) & (US$ Million)
 Table 55. China TCM Recent Development
 Table 56. Tsumura Company Details
 Table 57. Tsumura Business Overview
 Table 58. Tsumura Plant Derivative Drug Product
 Table 59. Tsumura Revenue in Plant Derivative Drug Business (2020-2025) & (US$ Million)
 Table 60. Tsumura Recent Development
 Table 61. Schwabe Company Details
 Table 62. Schwabe Business Overview
 Table 63. Schwabe Plant Derivative Drug Product
 Table 64. Schwabe Revenue in Plant Derivative Drug Business (2020-2025) & (US$ Million)
 Table 65. Schwabe Recent Development
 Table 66. Tong Ren Tang Company Details
 Table 67. Tong Ren Tang Business Overview
 Table 68. Tong Ren Tang Plant Derivative Drug Product
 Table 69. Tong Ren Tang Revenue in Plant Derivative Drug Business (2020-2025) & (US$ Million)
 Table 70. Tong Ren Tang Recent Development
 Table 71. Jumpcan Pharmaceutical Company Details
 Table 72. Jumpcan Pharmaceutical Business Overview
 Table 73. Jumpcan Pharmaceutical Plant Derivative Drug Product
 Table 74. Jumpcan Pharmaceutical Revenue in Plant Derivative Drug Business (2020-2025) & (US$ Million)
 Table 75. Jumpcan Pharmaceutical Recent Development
 Table 76. Guangzhou Baiyunshan Pharmaceutical Company Details
 Table 77. Guangzhou Baiyunshan Pharmaceutical Business Overview
 Table 78. Guangzhou Baiyunshan Pharmaceutical Plant Derivative Drug Product
 Table 79. Guangzhou Baiyunshan Pharmaceutical Revenue in Plant Derivative Drug Business (2020-2025) & (US$ Million)
 Table 80. Guangzhou Baiyunshan Pharmaceutical Recent Development
 Table 81. Yunnan Baiyao Company Details
 Table 82. Yunnan Baiyao Business Overview
 Table 83. Yunnan Baiyao Plant Derivative Drug Product
 Table 84. Yunnan Baiyao Revenue in Plant Derivative Drug Business (2020-2025) & (US$ Million)
 Table 85. Yunnan Baiyao Recent Development
 Table 86. Tasly Holding Group Company Details
 Table 87. Tasly Holding Group Business Overview
 Table 88. Tasly Holding Group Plant Derivative Drug Product
 Table 89. Tasly Holding Group Revenue in Plant Derivative Drug Business (2020-2025) & (US$ Million)
 Table 90. Tasly Holding Group Recent Development
 Table 91. Bionorica Se Company Details
 Table 92. Bionorica Se Business Overview
 Table 93. Bionorica Se Plant Derivative Drug Product
 Table 94. Bionorica Se Revenue in Plant Derivative Drug Business (2020-2025) & (US$ Million)
 Table 95. Bionorica Se Recent Development
 Table 96. Huarun 999 Company Details
 Table 97. Huarun 999 Business Overview
 Table 98. Huarun 999 Plant Derivative Drug Product
 Table 99. Huarun 999 Revenue in Plant Derivative Drug Business (2020-2025) & (US$ Million)
 Table 100. Huarun 999 Recent Development
 Table 101. Taiji Company Details
 Table 102. Taiji Business Overview
 Table 103. Taiji Plant Derivative Drug Product
 Table 104. Taiji Revenue in Plant Derivative Drug Business (2020-2025) & (US$ Million)
 Table 105. Taiji Recent Development
 Table 106. Weleda Company Details
 Table 107. Weleda Business Overview
 Table 108. Weleda Plant Derivative Drug Product
 Table 109. Weleda Revenue in Plant Derivative Drug Business (2020-2025) & (US$ Million)
 Table 110. Weleda Recent Development
 Table 111. Kwangdong Company Details
 Table 112. Kwangdong Business Overview
 Table 113. Kwangdong Plant Derivative Drug Product
 Table 114. Kwangdong Revenue in Plant Derivative Drug Business (2020-2025) & (US$ Million)
 Table 115. Kwangdong Recent Development
 Table 116. GW Pharmaceuticals Company Details
 Table 117. GW Pharmaceuticals Business Overview
 Table 118. GW Pharmaceuticals Plant Derivative Drug Product
 Table 119. GW Pharmaceuticals Revenue in Plant Derivative Drug Business (2020-2025) & (US$ Million)
 Table 120. GW Pharmaceuticals Recent Development
 Table 121. Research Programs/Design for This Report
 Table 122. Key Data Information from Secondary Sources
 Table 123. Key Data Information from Primary Sources
 Table 124. Authors List of This Report


List of Figures
 Figure 1. Plant Derivative Drug Picture
 Figure 2. Global Plant Derivative Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Plant Derivative Drug Market Share by Type: 2024 VS 2031
 Figure 4. Prescription Drug Features
 Figure 5. OTC Features
 Figure 6. Global Plant Derivative Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Plant Derivative Drug Market Share by Application: 2024 VS 2031
 Figure 8. Cardiovascular Case Studies
 Figure 9. Tumor Case Studies
 Figure 10. Respiratory System Case Studies
 Figure 11. Other Case Studies
 Figure 12. Plant Derivative Drug Report Years Considered
 Figure 13. Global Plant Derivative Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Plant Derivative Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Plant Derivative Drug Market Share by Region: 2024 VS 2031
 Figure 16. Global Plant Derivative Drug Market Share by Players in 2024
 Figure 17. Global Top Plant Derivative Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plant Derivative Drug as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Plant Derivative Drug Revenue in 2024
 Figure 19. North America Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Plant Derivative Drug Market Share by Country (2020-2031)
 Figure 21. United States Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Plant Derivative Drug Market Share by Country (2020-2031)
 Figure 25. Germany Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Plant Derivative Drug Market Share by Region (2020-2031)
 Figure 33. China Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Plant Derivative Drug Market Share by Country (2020-2031)
 Figure 41. Mexico Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Plant Derivative Drug Market Share by Country (2020-2031)
 Figure 45. Turkey Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Plant Derivative Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Buchang Pharmaceuticals Revenue Growth Rate in Plant Derivative Drug Business (2020-2025)
 Figure 49. China TCM Revenue Growth Rate in Plant Derivative Drug Business (2020-2025)
 Figure 50. Tsumura Revenue Growth Rate in Plant Derivative Drug Business (2020-2025)
 Figure 51. Schwabe Revenue Growth Rate in Plant Derivative Drug Business (2020-2025)
 Figure 52. Tong Ren Tang Revenue Growth Rate in Plant Derivative Drug Business (2020-2025)
 Figure 53. Jumpcan Pharmaceutical Revenue Growth Rate in Plant Derivative Drug Business (2020-2025)
 Figure 54. Guangzhou Baiyunshan Pharmaceutical Revenue Growth Rate in Plant Derivative Drug Business (2020-2025)
 Figure 55. Yunnan Baiyao Revenue Growth Rate in Plant Derivative Drug Business (2020-2025)
 Figure 56. Tasly Holding Group Revenue Growth Rate in Plant Derivative Drug Business (2020-2025)
 Figure 57. Bionorica Se Revenue Growth Rate in Plant Derivative Drug Business (2020-2025)
 Figure 58. Huarun 999 Revenue Growth Rate in Plant Derivative Drug Business (2020-2025)
 Figure 59. Taiji Revenue Growth Rate in Plant Derivative Drug Business (2020-2025)
 Figure 60. Weleda Revenue Growth Rate in Plant Derivative Drug Business (2020-2025)
 Figure 61. Kwangdong Revenue Growth Rate in Plant Derivative Drug Business (2020-2025)
 Figure 62. GW Pharmaceuticals Revenue Growth Rate in Plant Derivative Drug Business (2020-2025)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart